Kimberly-Clark (KMB) is close to selling its Kleenex and tissue businesses outside North America for approximately $3.5B, Lauren Thomas and Ben Dummett of The Wall Street Journal reports. This move is part of an attempt by the company to focus on more profitable areas, people familiar with the matter told the Journal. The company is set to sell the division to Suzano (SUZ) and a deal could be completed as soon as Thursday, the sources added.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KMB:
- M&A News: Kimberly-Clark Eyes $3.5B Global Tissue Sale amid Portfolio Overhaul
- Joint Corp. appoints Karrmann as Director
- Kimberly-Clark Transfers Stock Listing to Nasdaq
- Kimberly-Clark to transfer its U.S. stock exchange listing to Nasdaq
- Kimberly Clark’s Strategic Reorganization and Growth Potential Earns Buy Rating